Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07672808 · ClinicalTrials.gov registry record · NA
Multimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use
A NA study, sponsored by Henry Ford Health System.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07672808 is a NA study that has not yet begun recruiting, run by Henry Ford Health System. The registered enrollment target is 100 participants.
The verdict
NCT07672808, a NA study, has not yet begun recruiting, sponsored by Henry Ford Health System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study examines whether patients undergoing total hip replacement surgery can manage their pain effectively while using fewer opioid pain medications. Participants will be randomly assigned to one of two groups. The first group will receive the standard postoperative pain medication regimen, with all prescriptions sent directly to their pharmacy as usual. The second group will receive the same medications, but their opioid prescription will only be provided as a printed copy rather than being sent directly to the pharmacy, requiring them to choose whether to fill it. All participants will keep a pain journal and complete questionnaires about their medication intake over the first 21 days post-op as well as there function and wellbeing at follow up visits over 3 months. The goal is to determine whether this approach reduces opioid use while still adequately controlling pain after hip replacement surgery.
Interventions
- DRUG Standard Multimodal Analgesic Regimen with Opioid Prescription
- BEHAVIORAL Opioid-Reduced Multimodal Analgesic Regimen with Printed Prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07672808
The ClinicalTrials.gov registry entry for NCT07672808 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Multimodal Analgesic Regimen with Opioid Prescription is the first listed.
NCT07672808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07672808 about?
NCT07672808 is a clinical study titled "Multimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use". This study examines whether patients undergoing total hip replacement surgery can manage their pain effectively while using fewer opioid pain medications. Participants will be randomly assigned to one of two groups. The first group will receive the standard postoperative pain medication regimen, wit...
What is the current status of trial NCT07672808?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-06-01. Estimated completion is 2027-05-30.
What interventions are being tested in trial NCT07672808?
The interventions under investigation include: Standard Multimodal Analgesic Regimen with Opioid Prescription (DRUG), Opioid-Reduced Multimodal Analgesic Regimen with Printed Prescription (BEHAVIORAL).
Who is sponsoring clinical trial NCT07672808?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.